---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-005431"
form_type: "8-K"
ticker: "ACHC"
cik: "0001520697"
company_name: "Acadia Healthcare Company, Inc."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:15:58.670583+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Acadia Healthcare Q4 net loss $13.02/sh on $996M goodwill impairment; appoints new CEO

## Summary
- Q4 revenue $821.5M (+6.1% YoY); net loss $13.02/diluted share from $996.2M goodwill impairment.
- Adjusted EBITDA $99.8M (down 35% YoY) includes $52.7M PLGL reserve adjustment.
- FY 2025 adjusted EPS $2.00 vs $3.30; FY 2026 guidance: rev $3.37-3.45B, adj EPS $1.30-1.55.
- Debbie Osteen appointed CEO; full-year 2025 added 1,089 licensed beds.

## SEC filing metadata
- accession: 0001437749-26-005431
- form_type: 8-K
- ticker: ACHC
- cik: 0001520697
- company_name: Acadia Healthcare Company, Inc.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520697/000143774926005431/0001437749-26-005431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520697/000143774926005431/achc20260224_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-005431
- JSON: https://secwatch.observer/filing/0001437749-26-005431.json
- Plain text: https://secwatch.observer/filing/0001437749-26-005431.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.